Business Description
Theraclion
ISIN : FR0010120402
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.01 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | -0.95 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.41 | |||||
Beneish M-Score | -0.82 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.2 | |||||
3-Year EBITDA Growth Rate | 44.3 | |||||
3-Year EPS without NRI Growth Rate | 29.1 | |||||
3-Year FCF Growth Rate | 36.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -99.99 | |||||
12-1 Month Momentum % | -99.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 2.87 | |||||
Cash Ratio | 1.72 | |||||
Days Inventory | 382.06 | |||||
Days Sales Outstanding | 643.61 | |||||
Days Payable | 244.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -41.4 | |||||
Shareholder Yield % | -65.38 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 2.1 | |||||
Operating Margin % | -244.66 | |||||
Net Margin % | -286.44 | |||||
FCF Margin % | -202.58 | |||||
ROE % | -86.5 | |||||
ROA % | -20.62 | |||||
ROIC % | -27.58 | |||||
3-Year ROIIC % | 64.06 | |||||
ROC (Joel Greenblatt) % | -196.25 | |||||
ROCE % | -35.85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 11.39 | |||||
PB Ratio | 2.57 | |||||
EV-to-EBIT | -1.86 | |||||
EV-to-EBITDA | -4.24 | |||||
EV-to-Revenue | 6.79 | |||||
EV-to-FCF | -3.35 | |||||
Earnings Yield (Greenblatt) % | -53.76 | |||||
FCF Yield % | -17.82 |